107 related articles for article (PubMed ID: 7651912)
1. VIP receptor-effector system in rat harderian gland and its coupling to activation of type II thyroxine 5'-deiodinase.
Calvo JR; Caraballo MI; Pozo D; Segura JJ; Osuna C; Guerrero JM
Peptides; 1995; 16(3):551-7. PubMed ID: 7651912
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland.
Guerrero JM; Osuna C; Molinero P; Caraballo MI; Harmouch A; Pozo D; Rafii-el-Idrissi M; Garcia-Macias JF; Calvo JR
Microsc Res Tech; 1996 Jun; 34(2):139-43. PubMed ID: 8722708
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of receptors for VIP in rat peritoneal macrophage membranes.
Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ
Peptides; 1994; 15(2):309-15. PubMed ID: 8008637
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors in human liver.
Rodríguez-Henche N; Rodríguez-Pena MS; Guijarro LG; Prieto JC
Biochim Biophys Acta; 1994 Mar; 1221(2):193-8. PubMed ID: 8148398
[TBL] [Abstract][Full Text] [Related]
8. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
9. Binding of [125I]iodocyanopindolol by rat harderian gland crude membranes: kinetic characteristics and day-night variations.
Harmouch A; Osuna C; Rafii-el-Idrissi M; Calvo JR; Guerrero JM
Biosci Rep; 1996 Oct; 16(5):369-77. PubMed ID: 8913527
[TBL] [Abstract][Full Text] [Related]
10. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
11. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
12. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.
Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184
[TBL] [Abstract][Full Text] [Related]
13. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
[TBL] [Abstract][Full Text] [Related]
14. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
Simonneaux V; Kienlen-Campard P; Loeffler JP; Basille M; Gonzalez BJ; Vaudry H; Robberecht P; Pévet P
Neuroscience; 1998 Aug; 85(3):887-96. PubMed ID: 9639281
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
17. VIP receptor/effector system in liver membranes from cholestatic rats.
Rodriguez-Henche N; Guijarro LG; Bajo AM; Arilla E; Prieto JC
Peptides; 1994; 15(2):353-7. PubMed ID: 8008639
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties.
Laburthe M; Breant B; Rouyer-Fessard C
Eur J Biochem; 1984 Feb; 139(1):181-7. PubMed ID: 6321173
[TBL] [Abstract][Full Text] [Related]
19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]